Back to announcement
20240528_SDPC_Laporan Informasi dan Fakta Material_31643523.pdf
Other Text extracted SDPCSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 277/MPI/DIR/V/2024
Nama Perusahaan Millennium Pharmacon International Tbk
Kode Emiten SDPC
Lampiran 1
Peningkatan Modal Dasar dan Modal Ditempatkan dan disetor pada Entitas
Perihal
Anak Perseroan
Dengan ini kami untuk dan atas nama perusahaan menyampaikan Laporan Informasi atau Fakta Material sebagai
berikut:
Nama Emiten atau Perusahaan Publik Millennium Pharmacon International Tbk
Bidang Usaha Perdagangan dan Jasa
Telepon 021-270 85961; 270 85964
Faksimili 021-270 85958
Alamat Surat Elektronik (email) investor.relation@mpi-pharmaniaga.co.id
Tanggal Kejadian 22 Mei 2024
Jenis Informasi atau Fakta Material Peningkatan Modal Dasar dan Modal Ditempatkan dan disetor
pada Entitas Anak Perseroan
Uraian Informasi atau Fakta Material Peningkatan modal ditempatkan dan disetor pada Entitas
Anak Perseroan, PT Digital Pharma Andalan Indonesia
tersebut sejumlah Rp 3.850.000.000,-
Dampak kejadian, informasi atau fakta Tidak berdampak material terhadap kegiatan operasional,
material tersebut terhadap kegiatan hukum, kondisi keuangan, atau kelangsungan usaha Emiten
operasional, hukum, kondisi keuangan, atau Perusahaan Publik.
atau kelangsungan usaha Emiten atau
Perusahaan Publik Kepemilikan saham perseroan terhadap PT Digital Pharma
Andalan Indonesia menjadi 99,94%
Demikian untuk diketahui.
Hormat Kami,
Millennium Pharmacon International Tbk
Mohamad Fazly bin Hassan
Direktur
Millennium Pharmacon International Tbk
Crown Bungur Arteri Lantai 2-4, Jl. Sultan Iskandar Muda No.18, Kel. Kebayoran
Telepon : 021-270 85961; 270 85964, Fax : 021-270 85958, www.mpi-indonesia.co.id
Nama Pengirim Mohamad Fazly bin Hassan
Page 2
Jabatan Direktur
Tanggal dan Waktu 28-05-2024 17:54
Lampiran 1. Surat Penambahan Modal Entitas Anak.pdf
Dokumen ini merupakan dokumen resmi Millennium Pharmacon International Tbk yang tidak memerlukan tanda
tangan karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. Millennium Pharmacon International
Tbk bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 277/MPI/DIR/V/2024
Issuer Name Millennium Pharmacon International Tbk
Issuer Code SDPC
Attachment 1
Subject The increase of authorized capital and issued and paid up capital of the
subsidiary of the Company
The company hereby announce the Material Information or Facts Report as follows
Name of Issuer or Public Company Millennium Pharmacon International Tbk
Business Activities Perdagangan dan Jasa
Telephone 021-270 85961; 270 85964
Faximile 021-270 85958
Email Address investor.relation@mpi-pharmaniaga.co.id
Date of Event 22 May 2024
The increase of authorized capital and issued and paid up
Type of Material Information or Facts capital of the subsidiary of the Company
Description of Material Information or The increase of issued and paid up capital of the subsidiary of
Facts the Company, PT Digital Pharma Andalan Indonesia by an
amount IDR 3.850.000.000,-
Impact of event, material information or Does not have a material impact on operational activities, law,
facts towards Issuers or Public financial condition, or business continuity of the Issuer or
Company’s operational activities, legal, Public Company.
financial condition, or going concern
The company's share ownership in PT Digital Pharma Andalan
Indonesia becomes 99.94%
Thus to be informed accordingly.
Respectfully,
Millennium Pharmacon International Tbk
Mohamad Fazly bin Hassan
Direktur
Millennium Pharmacon International Tbk
Crown Bungur Arteri Lantai 2-4, Jl. Sultan Iskandar Muda No.18, Kel. Kebayoran
Phone : 021-270 85961; 270 85964, Fax : 021-270 85958, www.mpi-indonesia.co.id
Sender Name Mohamad Fazly bin Hassan
Function Direktur
Date and Time 28-05-2024 17:54
Page 4
Attachment 1. Surat Penambahan Modal Entitas Anak.pdf
This is an official document of Millennium Pharmacon International Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. Millennium Pharmacon International Tbk is fully
responsible for the information contained within this document.
Names mentioned 4 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Digital Pharma Andalan Indonesia
p.1 ×4
unresolved
person
Mohamad Fazly bin Hassan
· Nama Pengirim
p.1 ×3
unresolved
person
Function
· Direktur
p.3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.